Skip to search.
 FTSE 100 Down 0.28%

KaloBios Pharmaceuticals, Inc. (KBIO)

-Other OTC
3.49 Up 0.09(2.65%) 25 Aug 20:37
Prev Close:3.40
Open:3.40
Bid:N/A
Ask:N/A
1y Target Est:5.00
Beta:3.51626
Next Earnings Date:N/A
Day's Range:3.35 - 3.64
52wk Range:0.44 - 45.82
Volume:4,000
Avg Vol (3m):26,809
Market Cap:50.53m
P/E (ttm):N/A
EPS (ttm):-8.11
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for KBIO at this time.

Comparison

Symbol% ChgMkt Cap
KBIOUp 2.65%50.53m
VRTXDown 0.34%23.88b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :N/A
Quarterly EPS Est (Sep-15) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

KaloBios Pharmaceuticals, Inc., a biopharmaceutical company, develops monoclonal antibody therapeutics for the treatment of cancer in the United States. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback